Dr Reddys Laboratories consolidated net profit declines 82.59% in the March 2022 quarter

19 May 2022 , 01:36 PM

Net profit of Dr Reddys Laboratories declined 82.59% to Rs 97.00 crore in the quarter ended March 2022 as against Rs 557.30 crore during the previous quarter ended March 2021. Sales rose 14.98% to Rs 5436.80 crore in the quarter ended March 2022 as against Rs 4728.40 crore during the previous quarter ended March 2021. For the full year,net profit rose 11.83% to Rs 2182.50 crore in the year ended March 2022 as against Rs 1951.60 crore during the previous year ended March 2021. Sales rose 13.00% to Rs 21439.10 crore in the year ended March 2022 as against Rs 18972.20 crore during the previous year ended March 2021.

Particulars	Quarter Ended	Year Ended
?	Mar. 2022	Mar. 2021	% Var.	Mar. 2022	Mar. 2021	% Var.
Sales	5436.80	4728.40	15	21439.10	18972.20	13
OPM %	8.30	22.27	–	17.57	20.40	–
PBDT	551.90	1124.00	-51	4226.60	4112.30	3
PBT	258.90	815.20	-68	3061.40	2883.50	6
NP	97.00	557.30	-83	2182.50	1951.60	12

Powered by Capital Market – Live News